These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15535207)

  • 1. [Genetic abnormality in cervical cancer].
    Umayahara K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():66-8. PubMed ID: 15535207
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular abnormalities in lung cancer].
    Shimizu S; Mitsudomi T
    Nihon Rinsho; 2002 May; 60 Suppl 5():73-7. PubMed ID: 12101773
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanism in carcinogenesis of the uterine cervix].
    Nakagawa S; Taketani Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():73-7. PubMed ID: 15535209
    [No Abstract]   [Full Text] [Related]  

  • 10. p53 polymorphism and risk of cervical cancer.
    Josefsson AM; Magnusson PK; Ylitalo N; Quarforth-Tubbin P; Pontén J; Adami HO; Gyllensten UB
    Nature; 1998 Dec; 396(6711):531; author reply 532. PubMed ID: 9859988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [P53 protein and human papillomavirus oncogenes in carcinogenesis of the uterine cervix].
    Toledo-Cuevas EM; García-Carrancá A
    Rev Invest Clin; 1996; 48(1):59-68. PubMed ID: 8815489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of VEGF, KDR, p53, E6 HPV16 and HPV18 in vulvar and cervix cancer].
    Michalski B; Mazurek U; Olejek A; Kuśmierz D; Poreba R; Witek A; Wilczok T
    Wiad Lek; 2000; 53(5-6):240-6. PubMed ID: 10983377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer.
    von Knebel Doeberitz M; Spitkovsky D; Ridder R
    Verh Dtsch Ges Pathol; 1997; 81():233-9. PubMed ID: 9474875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
    Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormal fragile histidine triad and cervical cancer].
    Machida S; Saga Y; Ohwada M; Suzuki M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():69-72. PubMed ID: 15535208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.